We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Organicell

News List

Organicell Announces FDA Approval Of IND Application For The Use Of Zofin™ In COVID-19 Long Haulers prnewswire
July 22, 2021
announced today that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for its lead product, Zofin™, for the treatment of 'Prolonged COVID-19 Symptoms' ("Long Haulers").
Pakistan approves Zofin™ for compassionate use in COVID-19 patient europeanpharmaceuticalreview
May 13, 2021
Organicell’s Zofin™ therapy has been approved by the Pakistani regulators to be used for a patient with severe COVID-19 on compassionate grounds.
100 percent recovery rate for COVID-19 patients treated with Zofin™ europeanpharmaceuticalreview
April 30, 2021
The first ten patients in a Phase I trial of Zofin™ have recovered and been discharged, the trial will now expand with an additional 65 participants.